Skip to main content
Top
Published in: Medical Oncology 4/2015

01-04-2015 | Original Paper

Down-expression pattern of Ku70 and p53 coexisted in colorectal cancer

Authors: Yuanfang Lu, Jingyan Gao, Yuanming Lu

Published in: Medical Oncology | Issue 4/2015

Login to get access

Abstract

To address the relationship of altered expression of double-strand break repair proteins Ku70 and p53 in clinical colorectal cancer (CRC), we examined the expression pattern of Ku70 and p53 by using fluorescent immunohistochemistry and real-time PCR assays in CRC and pericancerous samples from 152 Chinese patients. The results showed that down-expression pattern of both Ku70 and p53 coexisted in the CRC samples with significant correlating rate (R 2 = 0.9103; P < 0.001), and the down-expression of Ku70 and p53 was significantly associated with the advanced tumor node metastasis stage (Ku70: HR 3.453 in recurrence and 4.182 in survival, P < 0.001; P53: HR 3.114 in recurrence and 4.113 in survival, P < 0.001). The down-regulated Ku70 and p53 were associated with poor disease-free survival. Loss of Ku70 and p53 expression might serve as a biomarker of poor prognosis in CRC patients.
Literature
1.
go back to reference Jernal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRef Jernal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRef
2.
go back to reference Sung JJ, Lau JY, Goh KL, Leung WK. Increasing incidence of colorectal cancer in Asian: implications for screening. Lancet Oncol. 2005;11:871–6.CrossRef Sung JJ, Lau JY, Goh KL, Leung WK. Increasing incidence of colorectal cancer in Asian: implications for screening. Lancet Oncol. 2005;11:871–6.CrossRef
3.
go back to reference DeVita VT Jr, Hellmann S, Rosemberg SA. Cancer principles and practice of oncology, vol. 28. Philadelphia: Lippincott-Raven; 1997. p. 1144–97. DeVita VT Jr, Hellmann S, Rosemberg SA. Cancer principles and practice of oncology, vol. 28. Philadelphia: Lippincott-Raven; 1997. p. 1144–97.
4.
5.
go back to reference Rouse J, Jackson SP. Interfaces between the detection, signaling, and repair of DNA damage. Science. 2002;297:547–51.CrossRefPubMed Rouse J, Jackson SP. Interfaces between the detection, signaling, and repair of DNA damage. Science. 2002;297:547–51.CrossRefPubMed
6.
go back to reference Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet. 2001;27:247–54.CrossRefPubMed Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet. 2001;27:247–54.CrossRefPubMed
7.
go back to reference van Gent DC, Hoeijmakers JHJ, Kanaar R. Chromosomal stability and the DNA double-strand breakconnection. Nat Rev Genet. 2001;2:196–206.CrossRefPubMed van Gent DC, Hoeijmakers JHJ, Kanaar R. Chromosomal stability and the DNA double-strand breakconnection. Nat Rev Genet. 2001;2:196–206.CrossRefPubMed
8.
go back to reference Zhou B-BS, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature. 2001;408:433–9. Zhou B-BS, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature. 2001;408:433–9.
9.
go back to reference Mills KD, Ferguson DO, Alt FW. The role of DNA breaks in genomic instability and tumorigenesis. Immunol Rev. 2003;194:77–95.CrossRefPubMed Mills KD, Ferguson DO, Alt FW. The role of DNA breaks in genomic instability and tumorigenesis. Immunol Rev. 2003;194:77–95.CrossRefPubMed
10.
go back to reference Chen G, Yuan SS, Liu W, et al. Radiation-induced assembly of Rad51 and Rad52 recombination complex requires p53 and c-Abl. J Biol Chem. 1999;18:12748–52.CrossRef Chen G, Yuan SS, Liu W, et al. Radiation-induced assembly of Rad51 and Rad52 recombination complex requires p53 and c-Abl. J Biol Chem. 1999;18:12748–52.CrossRef
12.
go back to reference Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–8.CrossRefPubMed Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–8.CrossRefPubMed
13.
go back to reference Monika P, Andrzej S, Przemyslaw B. H2AX phosphorylation: its Role in DNA damage response and cancer therapy. J Nucleic Acids. 2010;3:2010. Monika P, Andrzej S, Przemyslaw B. H2AX phosphorylation: its Role in DNA damage response and cancer therapy. J Nucleic Acids. 2010;3:2010.
14.
go back to reference Lanuszewska J, Widlak P. The truncation of Ku86 in human lymphocytes. Cancer Lett. 2004;205:197–205.CrossRefPubMed Lanuszewska J, Widlak P. The truncation of Ku86 in human lymphocytes. Cancer Lett. 2004;205:197–205.CrossRefPubMed
15.
go back to reference Lieber MR, Ma Y, Pannicke U, Schwarz K. Mechanism and regulation of human non-homologous DNA end-joining. Nat Rev Mol Cell Biol. 2003;4:712–20.CrossRefPubMed Lieber MR, Ma Y, Pannicke U, Schwarz K. Mechanism and regulation of human non-homologous DNA end-joining. Nat Rev Mol Cell Biol. 2003;4:712–20.CrossRefPubMed
16.
go back to reference Choi REK, Lee YH, Choi YS, et al. Heterogeneous expression of Ku70 in human tissues is associated with morphological and functional alterations of the nucleus. J Pathol. 2004;198:121–30.CrossRef Choi REK, Lee YH, Choi YS, et al. Heterogeneous expression of Ku70 in human tissues is associated with morphological and functional alterations of the nucleus. J Pathol. 2004;198:121–30.CrossRef
17.
go back to reference Grabsch H, Dattani M, Barker L, et al. Expression of DNA double-strand break repair proteins p53 and BRCA1 predicts survival in colorectal cancer. Clin Cancer Res. 2006;5:1494–500.CrossRef Grabsch H, Dattani M, Barker L, et al. Expression of DNA double-strand break repair proteins p53 and BRCA1 predicts survival in colorectal cancer. Clin Cancer Res. 2006;5:1494–500.CrossRef
18.
go back to reference Komuro Y, Watanabe T, Hosoi Y. The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma. Cancer. 2002;95:1199–205.CrossRefPubMed Komuro Y, Watanabe T, Hosoi Y. The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma. Cancer. 2002;95:1199–205.CrossRefPubMed
19.
go back to reference Andrew DB, EEnric D, McGregor M, et al. Loss of expression of p53 is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN. Oncotarget. 2012;11:1348–55. Andrew DB, EEnric D, McGregor M, et al. Loss of expression of p53 is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN. Oncotarget. 2012;11:1348–55.
20.
go back to reference Ponnala S, Veeraballi KK, Chetty C, et al. Regulation of DNA repair mechanism in human glioma xenograft cells both in vitro and in vivo in nude mice. PLoS One. 2011;10:31–40. Ponnala S, Veeraballi KK, Chetty C, et al. Regulation of DNA repair mechanism in human glioma xenograft cells both in vitro and in vivo in nude mice. PLoS One. 2011;10:31–40.
21.
go back to reference Singh K, Matsuyama S, Drazba JA, et al. Autophagy-dependent senescence in response to DNA damage and chronic apoptotic stress. Autophagy. 2012;2:236–51.CrossRef Singh K, Matsuyama S, Drazba JA, et al. Autophagy-dependent senescence in response to DNA damage and chronic apoptotic stress. Autophagy. 2012;2:236–51.CrossRef
22.
go back to reference Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet. 2001;3:247–54.CrossRef Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet. 2001;3:247–54.CrossRef
Metadata
Title
Down-expression pattern of Ku70 and p53 coexisted in colorectal cancer
Authors
Yuanfang Lu
Jingyan Gao
Yuanming Lu
Publication date
01-04-2015
Publisher
Springer US
Published in
Medical Oncology / Issue 4/2015
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-015-0519-9

Other articles of this Issue 4/2015

Medical Oncology 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.